Sign In
News Digest /
Ticker: MRK
Ticker: MRK
03:27am, Tuesday, May 12, 2026
Jiangsu Hengrui Pharmaceuticals' shares soared after announcing a global oncology and immunology development deal with Bristol-Myers Squibb worth up to $15.2 billion.
07:46am, Wednesday, Mar 25, 2026
Merck is set to acquire Terns Pharmaceuticals for $6.7 billion, enhancing its oncology portfolio with TERN-701, a promising drug candidate targeting chronic myeloid leukemia.
07:44am, Thursday, Nov 20, 2025
Moderna lands a $1.5 billion loan from Ares Management and forecasts a 10% revenue lift next year despite recent pipeline cuts. The biotech readies new vaccine launches to reclaim market share.
07:02am, Wednesday, Aug 06, 2025
Trump's tariff moves reshape global trade, easing EU tensions but hiking duties on copper and low-value imports. Key deadlines in August-September may escalate US-China friction and pressure drugmakers like Eli Lilly and Pfizer on pricing.
08:58am, Wednesday, Jul 09, 2025
Merck (MRK) announces a $10 billion acquisition of Verona Pharma (VRNA) to expand its portfolio and reduce reliance on Keytruda, set for patent expiration. The deal includes access to Ohtuvayre, a COPD treatment, boosting investor confidence and sales potential.
05:41am, Wednesday, Apr 30, 2025
Merck & Co. plans to invest $1 billion in a Delaware manufacturing plant, enhancing domestic production and creating 4,000 jobs. This facility will produce Keytruda, bolstering Merck's supply chain amid tariff pressures, marking a key move in U.S. pharma manufacturing.
09:20am, Thursday, Apr 24, 2025
Merck & Co. (NYSE: MRK) has adjusted its 2025 earnings forecast to $8.82-$8.97 per share due to $200M in tariffs and a licensing charge. Despite a 2% revenue dip, Q1 results exceeded expectations, with Keytruda sales of $7.21B. Investors should monitor tariff impacts and new drug performance.
06:56am, Tuesday, Feb 04, 2025
Key companies reporting earnings on February 4, 2025, include Google (GOOGL, GOOG), Toyota (TM), Merck (MRK), Pfizer (PFE), Pepsico (PEP), and AMD (AMD). Investors should watch for insights that could influence market sentiment and stock movements.
09:28am, Monday, Feb 03, 2025
Investors eagerly await earnings reports this week from key players like Google, Toyota, Amazon, Alibaba, Eli Lilly, and Merck. These results will provide critical insights into the technology, automotive, and pharmaceutical sectors, influencing market dynamics.
09:09am, Tuesday, Jun 18, 2024
Apple ends Pay Later program, S&P 500 reaches record high driven by tech stocks, Nvidia's influence in tech index rises. Learn about the latest financial updates.
03:14am, Tuesday, May 28, 2024
Hedge funds are pivoting towards dividend stock Merck & Co (NYSE: MRK), accumulating over $8.11 billion in shares. Merck’s robust sales, consistent dividends, and blockbuster cancer drug lineup make it a favored choice. Meanwhile, EquityMultiple’s Ascent Income Fund offers a high-yield alternativ...